ICAAC 48th/IDSA 46th

Title Content type
Pharmacokinetics and Pharmacodynamics of a Novel Triazole, Isavuconazole (BAL8557): Mathematical Modeling, the Importance of Tissue Concentrations and the Impact of Immune Status on the Antifungal Effect (click for details)
The in vitro Activity of Isavuconazole against Aspergillus Species andZygomycetes According to EUCAST Methodology (click for details)
Antifungal Susceptibility Among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans (click for details)
M-1525 Antifungal Activity of Old and New Antifungal Agents Against 93 Clinical Isolates ofCryptococcus neoformans var. grubii and var. neoformans: Are there Differences Between the Varieties? (click for details)
Endophthalmitis Caused by Filamentous Fungi is Associated with a Poor Prognosis in Immunocompromised Patients (pts) (click for details)
Neutrophils but not Alveolar Macrophages are Essential at Early Time Points Following Aspergillus Infection (click for details)
Epidemiology of Non-Candida Mycotic Infections in Mechanically Ventilated Patients (click for details)
Invasive Aspergillosis in Acute Myeloid Leukemia: Report of SEIFEM-2008 Registry (click for details)
Antifungal Effects of Triazoles and Caspofungin Combined with Human Neutrophils (PMNs) against Hyphae of Different Zygomycetes (click for details)
In Vivo Efficacy of Posaconazole Against Laboratory-Selected Voriconazole-Resistant Aspergillus fumigatus in a Neutropenic Murine Pulmonary Aspergillosis Model (click for details)


Subscribe to ICAAC 48th/IDSA 46th